JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J. Biol. Chem., Vol. 283, Issue 28, 99934, July 11, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Author Profile
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

RNA Polymerase III and Cancer{diamondsuit}

RNA polymerase III transcription, responsible for synthesizing many un-translated RNAs such as 5 S ribosomal and transfer RNA, is deregulated in tumor cells, although it's not known if this is a cause or consequence of cell transformation. In this Paper of the Week, Sandra Johnson and colleagues demonstrate that enhanced RNA pol III transcription is indeed required, although not sufficient, for full tumor potential. In oncogenic fibroblasts displaying enhanced RNA pol III activity (via TBP (TATA-binding protein) or c-Myc activation), decreasing the expression of the pol III transcription factor Brf1 could subsequently decrease pol III transcription. Although Brf1 suppression did not slow down the proliferation of the transformed fibroblasts, it did prevent anchorage-independent tumor growth in soft agar and tumor formation in mice. On the other hand, increasing Brf1 expression in normal cells could not by itself promote cellular transformation, suggesting that enhanced pol III activity works in concert with other factors in tumorigenesis. Johnson and colleagues believe this work should solidify RNA pol III machinery as a viable target in anti-cancer therapy.Go


Figure 1
Although suppressing the RNA pol III transcription factor Brf1 doesn't slow down cell proliferation in cancer cells (left), it does significantly reduce anchorage-independent colony growth (right).

FOOTNOTES

{diamondsuit} See referenced article, J. Biol. Chem. 2008, 283, 19184-19191 Back



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Author Profile
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.